Cargando…

Systemic therapy for metastatic renal cell carcinoma in the first-line setting: a systematic review and network meta-analysis

PURPOSE: Management of metastatic renal cell cancer (mRCC) has undergone a paradigm shift with immune-checkpoint inhibitors (ICI) in the first-line setting. However, direct comparative data are inadequate to inform treatment decisions. Therefore, we aimed to assess first-line therapy for mRCC and in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Keiichiro, Mostafaei, Hadi, Miura, Noriyoshi, Karakiewicz, Pierre I., Luzzago, Stefano, Schmidinger, Manuela, Bruchbacher, Andreas, Pradere, Benjamin, Egawa, Shin, Shariat, Shahrokh F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889529/ https://www.ncbi.nlm.nih.gov/pubmed/32757054 http://dx.doi.org/10.1007/s00262-020-02684-8

Ejemplares similares

Prognostic value of preoperative hematologic biomarkers in urothelial carcinoma of the bladder treated with radical cystectomy: a systematic review and meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2020)

Prognostic effect of preoperative serum albumin to globulin ratio in patients treated with cytoreductive nephrectomy for metastatic renal cell carcinoma
por: Laukhtina, Ekaterina, et al.
Publicado: (2021)

Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2020)

Systemic therapies for metastatic hormone‐sensitive prostate cancer: network meta‐analysis
por: Mori, Keiichiro, et al.
Publicado: (2021)

Performance of fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography imaging for lymph node staging in bladder and upper tract urothelial carcinoma: a systematic review
por: Aydh, Abdulmajeed, et al.
Publicado: (2020)

Outcome of immune checkpoint inhibitors in metastatic renal cell carcinoma across different treatment lines
por: Resch, I., et al.
Publicado: (2021)

Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta‐analyses
por: Mostafaei, Hadi, et al.
Publicado: (2021)

Prognostic value of the pre-operative serum albumin to globulin ratio in patients with non-metastatic prostate cancer undergoing radical prostatectomy
por: Aydh, Abdulmajeed, et al.
Publicado: (2021)

Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC)
por: Laukhtina, Ekaterina, et al.
Publicado: (2020)

Selection and evaluation of preoperative systemic inflammatory response biomarkers model prior to cytoreductive nephrectomy using a machine-learning approach
por: Laukhtina, Ekaterina, et al.
Publicado: (2021)

Prognostic value of testosterone for the castration-resistant prostate cancer patients: a systematic review and meta-analysis
por: Miura, Noriyoshi, et al.
Publicado: (2020)

The recurrence and progression risk after simultaneous endoscopic surgery of urothelial bladder tumour and benign prostatic hyperplasia: a systematic review and meta‐analysis
por: Sari Motlagh, Reza, et al.
Publicado: (2020)

Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
por: Quhal, Fahad, et al.
Publicado: (2021)

Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis
por: Yanagisawa, Takafumi, et al.
Publicado: (2021)

Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration
por: Mori, Keiichiro, et al.
Publicado: (2021)

Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis
por: Yanagisawa, Takafumi, et al.
Publicado: (2023)

Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer
por: Mori, Keiichiro, et al.
Publicado: (2021)

A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma
por: Schuettfort, Victor M., et al.
Publicado: (2021)

Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2019)

Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic review
por: Laukhtina, Ekaterina, et al.
Publicado: (2021)

Influence of steep Trendelenburg position on postoperative complications: a systematic review and meta-analysis
por: Katayama, Satoshi, et al.
Publicado: (2021)

Psychological Distress in Patients Treated for Renal Cell Carcinoma: A Systematic Literature Review
por: Vartolomei, Liliana, et al.
Publicado: (2022)

Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets
por: Grossmann, Nico C, et al.
Publicado: (2021)

Association between previous negative biopsies and lower rates of progression during active surveillance for prostate cancer
por: Piccinelli, Mattia Luca, et al.
Publicado: (2022)

Radiation therapy compared to radical prostatectomy as first-line definitive therapy for patients with high-risk localised prostate cancer: An updated systematic review and meta-analysis
por: Aydh, Abdulmajeed, et al.
Publicado: (2022)

Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomy
por: Rajwa, Pawel, et al.
Publicado: (2021)

Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
por: Mori, Keiichiro, et al.
Publicado: (2022)

Intracorporeal versus extracorporeal urinary diversion in robot-assisted radical cystectomy: a systematic review and meta-analysis
por: Katayama, Satoshi, et al.
Publicado: (2021)

Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis
por: Schuettfort, Victor M., et al.
Publicado: (2020)

ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
por: Mori, Keiichiro, et al.
Publicado: (2022)

Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer
por: Schuettfort, Victor M., et al.
Publicado: (2021)

Optimal first-line and second-line treatments for metastatic renal cell carcinoma: current evidence
por: Sun, Maxine, et al.
Publicado: (2014)

Association between SARS-CoV-2 infection and disease severity among prostate cancer patients on androgen deprivation therapy: a systematic review and meta-analysis
por: Sari Motlagh, Reza, et al.
Publicado: (2021)

Dual immune checkpoint inhibition in metastatic renal cell carcinoma: Editorial re.: Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced RCC: extended 4-year follow-up of the phase III CheckMate 214 trial
por: Schmidinger, M., et al.
Publicado: (2021)

Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer
por: Katayama, Satoshi, et al.
Publicado: (2021)

Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2022)

Association of statins use and mortality outcomes in prostate cancer patients who received androgen deprivation therapy: a systematic review and meta-analysis
por: Aydh, Abdulmajeed, et al.
Publicado: (2021)

ASO Author Reflections: Is There Any Difference Among Various Gleason Scores Classified as Grade Group 4 Prostate Cancer?
por: Mori, Keiichiro, et al.
Publicado: (2021)

Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non‐muscle‐invasive bladder cancer: a systematic review and network meta‐analysis of randomized trials
por: Sari Motlagh, Reza, et al.
Publicado: (2021)

Predictive value of De Ritis ratio in metastatic renal cell carcinoma treated with tyrosine-kinase inhibitors
por: Janisch, Florian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o8agi63g8htjffst4edo5fa4vm